Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Pedersen

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
JAMA|April 24, 2008
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trialJaffer A Ajani, Kathryn A Winter, Leonard L Gunderson, et al.
Endocrine-Related Cancer|May 2, 2020
CRISP3 expression drives prostate cancer invasion and progressionMarianna Volpert, Luc Furic, Jinghua Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
US intergroup anal carcinoma trial: tumor diameter predicts for colostomyJaffer A Ajani, Kathryn A Winter, Leonard L Gunderson, et al.
Cancer|June 22, 2010
Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11)Jaffer A Ajani, Kathryn A Winter, Leonard L Gunderson, et al.
BJU International|November 17, 2011
The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volumeNiall M Corcoran, Rowan G Casey, Matthew K H Hong, et al.
BJU International|September 8, 2011
Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumoursNiall M Corcoran, Chris M Hovens, Matthew K H Hong, et al.
Bioorganic & Medicinal Chemistry|May 17, 2005
Novel semicarbazide-derived inhibitors of human dipeptidyl peptidase I (hDPPI)Jon Bondebjerg, Henrik Fuglsang, Kirsten Rosendal Valeur, et al.
BJU International|January 20, 2012
Positive surgical margins are a risk factor for significant biochemical recurrence only in intermediate-risk diseaseNiall M Corcoran, Chris M Hovens, Charles Metcalfe, et al.
Pathology|March 13, 2012
Microscopic assessment of fresh prostate tumour specimens yields significantly increased rates of correctly annotated samples for downstream analysisMichael Kerger, Matthew K H Hong, John Pedersen, et al.
Pathology, Research and Practice|October 17, 2017
3D modelling of radical prostatectomy specimens: Developing a method to quantify tumor morphometry for prostate cancer risk predictionMarcus C Hovens, Kevin Lo, Michael Kerger, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
JAMA|April 24, 2008
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trialJaffer A Ajani, Kathryn A Winter, Leonard L Gunderson, et al.
Endocrine-Related Cancer|May 2, 2020
CRISP3 expression drives prostate cancer invasion and progressionMarianna Volpert, Luc Furic, Jinghua Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
US intergroup anal carcinoma trial: tumor diameter predicts for colostomyJaffer A Ajani, Kathryn A Winter, Leonard L Gunderson, et al.
Cancer|June 22, 2010
Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11)Jaffer A Ajani, Kathryn A Winter, Leonard L Gunderson, et al.
BJU International|November 17, 2011
The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volumeNiall M Corcoran, Rowan G Casey, Matthew K H Hong, et al.
BJU International|September 8, 2011
Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumoursNiall M Corcoran, Chris M Hovens, Matthew K H Hong, et al.
Bioorganic & Medicinal Chemistry|May 17, 2005
Novel semicarbazide-derived inhibitors of human dipeptidyl peptidase I (hDPPI)Jon Bondebjerg, Henrik Fuglsang, Kirsten Rosendal Valeur, et al.
BJU International|January 20, 2012
Positive surgical margins are a risk factor for significant biochemical recurrence only in intermediate-risk diseaseNiall M Corcoran, Chris M Hovens, Charles Metcalfe, et al.
Pathology|March 13, 2012
Microscopic assessment of fresh prostate tumour specimens yields significantly increased rates of correctly annotated samples for downstream analysisMichael Kerger, Matthew K H Hong, John Pedersen, et al.
Pathology, Research and Practice|October 17, 2017
3D modelling of radical prostatectomy specimens: Developing a method to quantify tumor morphometry for prostate cancer risk predictionMarcus C Hovens, Kevin Lo, Michael Kerger, et al.
Pageof 10